Erratum: Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonist (Neuron (2024) 112(3) (384–403.e8), (S0896627323008048), (10.1016/j.neuron.2023.10.023))

Alexandra Litvinchuk, Jung H. Suh, Jing L. Guo, Karin Lin, Sonnet S. Davis, Nga Bien-Ly, Eric Tycksen, G. Travis Tabor, Javier Remolina Serrano, Melissa Manis, Xin Bao, Choonghee Lee, Megan Bosch, Enmanuel J. Perez, Carla M. Yuede, Anil G. Cashikar, Jason D. Ulrich, Gilbert Di Paolo, David M. Holtzman

Research output: Contribution to journalComment/debate

Abstract

(Neuron 112, 384–403.e1–e8; February 7, 2024) Unfortunately, we inadvertently duplicated the graphs in Figures 8C and 8D in the original publication of our article. The wrong dataset was inserted in Prism while transferring data from Excel. The quantification of EC/PC volume with the correct values is now corrected online. The corrected graph in Figure 8D depicts an ∼32% reduction in EC/PC volume in TE4 vs. E4 (from the average of 5.767 mm3 in E4 to 3.945 mm3 in TE4) and an ∼17% reduction in TE4/Abca1 vs. E4 (from the average of 5.767 mm3 in E4 to 4.802 mm3 in TE4/Abca1). The revised graph does not affect the interpretation of these data in the body of the manuscript, as we previously stated that relative to E4 mice, the TE4/Abca1 mice were protected from EC/PC atrophy when compared to TE4 mice. We regret the error.[Formula

Original languageEnglish
Pages (from-to)2079
Number of pages1
JournalNeuron
Volume112
Issue number12
DOIs
StatePublished - Jun 19 2024

Fingerprint

Dive into the research topics of 'Erratum: Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonist (Neuron (2024) 112(3) (384–403.e8), (S0896627323008048), (10.1016/j.neuron.2023.10.023))'. Together they form a unique fingerprint.

Cite this